Company research

Stevanato Group S.p.A. (STVN) stock fundamentals

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South A

As of 2026-10-09

Exchange
XNYS
Sector
Healthcare
Industry
Medical Instruments & Supplies

Read this company snapshot

Step 1 of 3

Daily valuation snapshot

Stevanato Group S.p.A.: source evidence dated 2026-10-09.

Daily close (USD)
$19.4
Market capitalization (USD)
$5,298,647,833.8
Price / earnings (TTM)
33.53
Price / book
3.04
What you should see

The source values and product destination above identify the example to inspect.

Step 2 of 3

What business is this, and what does its dated valuation mean?

Check the market day first. P/E uses trailing earnings; book value and market capitalization answer different questions.

Daily valuation dataset and column definitions
What you should see

Open the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.

Step 3 of 3

Research STVN in the app

Open the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.

Research STVN in the app
What you should see

Keep reporting dates and units beside the answer, and inspect its original citations.

Company overview

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. It operates through two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. The company offers drug containment solutions comprising pre-fillable syringes, cartridges, vials, and ampoules; in-vitro diagnostic solutions; drug delivery systems, including pen injectors, auto-injectors, and wearable injectors; diagnostic laboratory consumables; analytical and regulatory support services; medical devices; pharmaceutical visual inspection machines; assembling and packaging machines; glass forming machines; and after-sales services, such as spare parts and maintenance services. It also provides contract development and manufacturing services for customer-owned drug delivery devices. The company serves pharmaceutical, biotechnology, diagnostics, and life sciences companies; and drug product, glass packaging, and fill and finish contract manufacturers. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.

Daily valuation snapshot

See the complete daily valuation snapshot

These values come from the daily market snapshot dated 2026-10-09. TTM means trailing twelve months. Use the market date when comparing STVN with another company.

Scroll sideways to compare all columns. Select a heading to sort.

Daily close (USD)$19.4
Market capitalization (USD)$5,298,647,833.8
Price / earnings (TTM)33.53
Price / book3.04

Read STVN's valuation metrics

  1. Company size

    Stevanato Group S.p.A.'s recorded market capitalization is $5,298,647,833.8. It measures the market value of the company's equity, rather than its revenue or cash balance.

  2. Price relative to earnings

    STVN's recorded P/E is 33.53: about $33.53 of share price for each $1 of trailing annual earnings per share. Compare that multiple with earnings growth and companies in the same business.

  3. Price relative to book equity

    STVN's recorded price-to-book ratio is 3.04. That compares its market equity value with recorded book equity. Examine its business and balance sheet to understand why those values differ.

Research Stevanato Group S.p.A. with Aurora

Use the snapshot above to ask a specific question about STVN. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.

Continue the research

Follow STVN's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.

Aurora · AI research assistant

Try this in Aurora

Edit the request, then open it in Aurora. You choose when to send it.